Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin for Plaque Progression in AF
NCT02090075Phase 4Completed
- Sponsor
- The Lundquist Institute
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in Atrial fibrillation (AFib), sponsored by The Lundquist Institute. Started Sep 2014; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02090075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090075.